Dr. Fauci says Moderna’s COVID-19 vaccine could be approved by the FDA TOMORROW

Moderna’s coronavirus vaccine could be approved by the FDA on Thursday, Dr. Anthony Fauci said Wednesday afternoon.

A panel of expert advisers from the Food and Drug Administration (FDA) will meet tomorrow to discuss whether the agency will recommend that the second shot be given to Americans.

“Tomorrow, hopefully, the FDA will make a decision as to whether or not the Moderna messenger RNA vaccine will receive emergency approval,” said Dr. Fauci. CNBC.

Pfizer’s shot did not get the green light for more than 24 hours after the same panel recommended its approval at the end of last Thursday’s meeting.

That angered and frustrated Americans, including the President, whose Chief of Staff Mark Meadows reportedly took the job of Commissioner Dr. Stephen Hahn would have been threatened if Pfizer’s vaccine had not been approved Friday.

Dr. Fauci’s comments suggest that with one approval and preparations for distributing a COVID-19 vaccine under its belt, the FDA could go faster on Moderna’s shot.

A few days ago … 2.9 billion doses were shipped to 145 locations, and in the coming days to weeks, we hope, more and more doses will come with a combination of Pfizer and Moderna, if Moderna gets the EUA which I hope they will get, that by the time you get to the end of December, you should be able to give 40 million doses to 20 million people, ” explained Dr. Fauci explains.

His comments come as the first doses of a coronavirus vaccine – that of Pfizer – are spread across the country.

It is a historic and fearful step toward curbing the US pandemic, where more than 3,000 Americans died on Tuesday alone.

On Wednesday, one of the first 96 people to receive the shot in Alaska responded seriously to it.

Two British health workers had similar reactions and went into anaphylactic shock after receiving an injection of Pfizer on the first day of its introduction there.

The Alaskan woman, Juneau, Alaska, had no known history of drug allergies – unlike the two cases in the UK – which made her concerned about the shot.

Dr. Fauci was not surprised by the emergence of these responses – or that they were not discussed in any trial for Pfizer’s shot.

“Well, that’s why I think people need to understand that the issue of safety goes well beyond the boundaries of a clinical trial,” Dr. Fauci told CNBC.

Because if you’re in a clinical trial, for example, you give it, the Pfizer trial consisted of 44,000 people.

‘Once you decide to distribute the vaccine on a large scale, you’re talking millions and tens of millions and eventually hundreds of millions of doses. So you may see reactions that you did not see in the clinical trial … you might see reactions that you did not see in the clinical trial. ‘

In the UK, the official advice is that people with a history of severe allergies do not receive the injection of Pfizer.

The US has not issued similar official warnings, but Dr. Fauci said this could be the reason Americans with allergies skip this shot and wait for another one, or make sure that the location where they choose to get vaccinated has treatments for bad reactions, such as EpiPens, available.

Serious allergic reactions were also not reported in Moderna’s trial, but are likely to emerge in the FDA discussion on Thursday as the company’s injection is of the same type as Pfizer’s mRNA vaccine.